Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FTI-2148 is an inhibitor of RAS C-terminal mimetic dual farnesyl transferase (FT-1) and geranylgeranyl transferase-1 (GGT-1) (IC50s: 1.4 nM and 1.7 μM, respectively).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 16,100 | 10-14周 | ||
50 mg | ¥ 21,300 | 10-14周 | ||
100 mg | ¥ 27,500 | 10-14周 |
产品描述 | FTI-2148 is an inhibitor of RAS C-terminal mimetic dual farnesyl transferase (FT-1) and geranylgeranyl transferase-1 (GGT-1) (IC50s: 1.4 nM and 1.7 μM, respectively). |
靶点活性 | GGT-1:1.7 μM, FT-1:1.4 nM |
体外活性 | FTI-2148 (30 μM) inhibits the farnesylation of the exclusively farnesylated protein HDJ2 in all 3 RAS-transformed NIH3T3 cells [1]. FTI-2148 is against P. falciparum PFT(protein farnesyltransferase), Mammalian PFT(protein farnesyltransferase), and Mammalian PGGT-I (geranylgeranyltransferase-I) (IC50s: 15 nM, 0.82 nM and 1700 nM) [2]. |
体内活性 | FTI-2148 (subcutaneous injection; 25 mpk/day with a mini-pump; 14 days) inhibits tumor growth by 77%by the end of the 2-week treatment in Human Xenograft Nude Mouse Model. FTI-2148 (subcutaneous?injection; 100 mg/kg/day; 14 days) causes breast tumor regression in a?ras?transgenic mouse model. FTI-2148 (intraperitoneal?injection; 25 or 50 mpk/day with a mini-pump; started on day 15 and stopped on day 45 and restarted day 53-83) inhibits the tumor growth by 91% in human lung adenocarcinoma A-549 cells induced mouse model [1]. FTI-2148 (subcutaneous?injection; 100 mg/kg/day; 4 days) causes 85–88% inhibition of FTase with no inhibition of GGTase I enzymatic activity in breast tumors from mice in vivo?settings [3]. |
分子量 | 452.57 |
分子式 | C24H28N4O3S |
CAS No. | 251577-09-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
FTI-2148 251577-09-0 Others FTI 2148 FTI2148 Inhibitor inhibitor inhibit